Currently, PROSILICO serves 19 customers, including one big pharma company. Among them are
– Kancera (www.kancera.com)
– Red Glead Discovery (www.redglead.com)
– Forendo Pharma, Finland (http://forendo.com/)
– Noviga Research
– Umecrine Cognition
– Quretech Bio (http://quretech.com/)
– Redoxis (www.redoxis.se)
– Apodemus (www.apodemus.se)
– Pronoxis (www.pronoxis.com)
Partner with Chemnotia (www.chemnotia.com).
Read about our collaboration here (http://blog.chemnotia.com/).
Virtual design of drug and drug candidate analogues with superior properties.
Collaborates with University of Eastern Finland around prodrug-predictons.
Discussions with potential collaborators and customers are ongoing.
PROSILICO is supported (business development) by Uppsala Innovation Centre (http://www.uic.se/).
- “Your efforts get top grades”
- “You have taken in-silico to a new level”
– “Impressed!” (quote from a big pharma company)
– “Service minded”
- “Working with Prosilico was really good”
- “Prosilico’s unique, validated tools and referencing systems have been applied on our compounds. This has enabled improved DMPK and improvements of program-designs, overview, safety assurance, drug ability estimations and cost-effectiveness.”/Pharmnovo
- “Well predicted! Impressive! Congratulations!”